Home > Boards > US OTC > Miscellaneous > Zyla Life Sciences (ZCOR)

On September 28, 2018, Egalet Corporation (the “Company”)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
realfast95 Member Profile
Member Level 
Followed By 48
Posts 13,953
Boards Moderated 1
Alias Born 11/29/06
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:30:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/14/2019 4:11:59 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/13/2019 8:42:25 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/6/2019 11:25:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/30/2019 5:10:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/24/2019 7:45:31 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/24/2019 7:44:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/23/2019 9:12:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/30/2019 4:06:16 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 4:21:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2019 4:07:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 5:15:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/3/2019 5:47:19 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 7/3/2019 6:12:39 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2019 6:12:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/20/2019 4:21:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/20/2019 4:09:56 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/20/2019 4:09:36 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/11/2019 12:11:12 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/7/2019 5:23:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/6/2019 5:01:52 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/20/2019 4:20:28 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/17/2019 12:30:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 4:13:26 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/15/2019 5:10:31 PM
realfast95 Member Level  Friday, 09/28/18 05:31:38 PM
Re: None
Post # of 670 
On September 28, 2018, Egalet Corporation (the “Company”) notified the U.S. Food and Drug Administration that, for business reasons, the Company is discontinuing the manufacture and promotion of Arymo® ER (morphine sulfate) extended-release tablets (“ARYMO ER”) effective September 28, 2018 (the “Discontinuation”). As part of its notice, the Company requested that the Orange Book staff move ARYMO ER to the “Discontinued Drug Products List” of the Approved Drug Products and Therapeutic Equivalence Evaluations (Orange Book) publication, and that the User Fee staff note the discontinued status of the product.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist